Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Mitchell

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Current Biology : CB|March 8, 2016
The Initiator Methionine tRNA Drives Secretion of Type II Collagen from Stromal Fibroblasts to Promote Tumor Growth and AngiogenesisCassie J Clarke, Tracy J Berg, Joanna Birch, et al.
Molecular Cancer|May 21, 2026
Increased mRNA translation delays tumour initiation and exposes a therapeutic vulnerability in lung cancerLuis Pardo, Madeleine Moore, Ruhi Deshmukh, et al.
British Journal of Cancer|May 6, 2026
Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesisAlessandra I Riggio, Kerri Sweeney, Robin Shaw, et al.
Nature Cancer|January 29, 2024
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanomaMahnoor Mahmood, Eric Minwei Liu, Amy L Shergold, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Current Biology : CB|March 8, 2016
The Initiator Methionine tRNA Drives Secretion of Type II Collagen from Stromal Fibroblasts to Promote Tumor Growth and AngiogenesisCassie J Clarke, Tracy J Berg, Joanna Birch, et al.
Molecular Cancer|May 21, 2026
Increased mRNA translation delays tumour initiation and exposes a therapeutic vulnerability in lung cancerLuis Pardo, Madeleine Moore, Ruhi Deshmukh, et al.
British Journal of Cancer|May 6, 2026
Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesisAlessandra I Riggio, Kerri Sweeney, Robin Shaw, et al.
Nature Cancer|January 29, 2024
Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanomaMahnoor Mahmood, Eric Minwei Liu, Amy L Shergold, et al.
Pageof 5